BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3003145)

  • 1. Response to parathyroid hormone and 1,25-dihydroxyvitamin D3 of bone-derived cells isolated from normal children and children with abnormalities in skeletal development.
    Silve C; Grosse B; Tau C; Garabedian M; Fritsch J; Delmas PD; Cournot-Witmer G; Balsan S
    J Clin Endocrinol Metab; 1986 Mar; 62(3):583-90. PubMed ID: 3003145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
    van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA
    Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of messenger ribonucleic acid expression of 1 alpha,25-dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts.
    Nishimura A; Shinki T; Jin CH; Ohyama Y; Noshiro M; Okuda K; Suda T
    Endocrinology; 1994 Apr; 134(4):1794-9. PubMed ID: 8137744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses.
    Chen TL; Hauschka PV; Cabrales S; Feldman D
    Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation by retinoic acid of 1,25-dihydroxyvitamin D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line.
    Grigoriadis AE; Petkovich PM; Rosenthal EE; Heersche JN
    Endocrinology; 1986 Aug; 119(2):932-9. PubMed ID: 3015560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
    Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
    J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3.
    Griffin JE; Zerwekh JE
    J Clin Invest; 1983 Oct; 72(4):1190-9. PubMed ID: 6313754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone increases 1,25-dihydroxyvitamin D3 receptor levels and augments bioresponses in rat osteoblast-like cells.
    Chen TL; Hauschka PV; Feldman D
    Endocrinology; 1986 Mar; 118(3):1119-26. PubMed ID: 3004896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8.
    Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE
    J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25-dihydroxyvitamin D-3 and 24,25-dihydroxyvitamin D-3 affect parathormone (PTH) -sensitive adenylate cyclase activity and alkaline phosphatase secretion of osteoblastic cells through different mechanisms of action.
    Klem KH; Jablonski G; Saether O; Jarosz G; Gautvik KM; Gordeladze JO
    Biochim Biophys Acta; 1990 Sep; 1054(3):304-10. PubMed ID: 2169895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids.
    Beresford JN; Gallagher JA; Poser JW; Russell RG
    Metab Bone Dis Relat Res; 1984; 5(5):229-34. PubMed ID: 6333574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6).
    Duque G; Macoritto M; Dion N; Ste-Marie LG; Kremer R
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E723-30. PubMed ID: 15572658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnosis of vitamin D-dependent rickets, type II: response to 1,25-dihydroxyvitamin D in amniotic fluid cells and fetal tissues.
    Weisman Y; Jaccard N; Legum C; Spirer Z; Yedwab G; Even L; Edelstein S; Kaye AM; Hochberg Z
    J Clin Endocrinol Metab; 1990 Oct; 71(4):937-43. PubMed ID: 2169482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63.
    Lajeunesse D; Kiebzak GM; Frondoza C; Sacktor B
    Bone Miner; 1991 Sep; 14(3):237-50. PubMed ID: 1657256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone modulation of 25-hydroxyvitamin D3 metabolism by cultured chick kidney cells is mimicked and enhanced by forskolin.
    Henry HL
    Endocrinology; 1985 Feb; 116(2):503-10. PubMed ID: 2981664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.
    Gamblin GT; Liberman UA; Eil C; Downs RW; DeGrange DA; Marx SJ
    J Clin Invest; 1985 Mar; 75(3):954-60. PubMed ID: 3872316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific internalization and action of 1,25-dihydroxyvitamin D3 in cultured dermal fibroblasts from patients with X-linked hypophosphatemia.
    Adams JS; Gacad MA; Singer FR
    J Clin Endocrinol Metab; 1984 Sep; 59(3):556-60. PubMed ID: 6547728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D.
    Balsan S; Garabédian M; Larchet M; Gorski AM; Cournot G; Tau C; Bourdeau A; Silve C; Ricour C
    J Clin Invest; 1986 May; 77(5):1661-7. PubMed ID: 3009551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory effect of calcium-regulating hormones on the synthesis and/or secretion of bone gamma-carboxyglutamic acid-containing protein in chick embryonic calvaria in vitro.
    Tsutsumi C; Hoshiba K; Moriuchi S; Orimo H; Hosoya N
    J Nutr Sci Vitaminol (Tokyo); 1986 Apr; 32(2):157-69. PubMed ID: 3020205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.